The total return over the past 12 months is -25.57% vs. +16.94% for the S&P 500. So far it's up -67.00% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (25.57%) | (13.44%) | (21.50%) | N/A | N/A | N/A |
| Total Return CAGR | (25.57%) | (13.44%) | (21.50%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Olema Pharmaceuticals, Inc. (OLMA)
| Year | Start price | End price | OLMA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $25.00 | $8.25 | (67.00%) | +14.51% | (81.51%) |
| 2025 | $5.83 | $25.00 | +328.82% | +17.72% | +311.10% |
| 2024 | $14.03 | $5.83 | (58.45%) | +24.89% | (83.34%) |
| 2023 | $2.45 | $14.03 | +472.65% | +26.19% | +446.46% |
| 2022 | $9.36 | $2.45 | (73.82%) | (18.17%) | (55.65%) |
| 2021 | $48.08 | $9.36 | (80.53%) | +28.74% | (109.27%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
